@kervio 180 already enrolled, but I think the sudden decision to not give any timelines on when these patients were enrolled/current numbers may have to do with Novartis throwing down a power move. i.e. Novartis don't want the public to know exact timelines anymore, and obv. if they are about to do a share placement they want the SPP to be as low as possible. Hence, the recent decision to stop providing these details.
In any event, with Texas Health Institute and Novartis behind the scenes, I would imagine we would speed up enrollment and likely get the next 120 patients before 31 December 2020 - assuming the current number is 180, that is.
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-386
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |